However, a recent meta-analysis examining the relationship between APOE genotype and AD-dementia risk between men and women found no significant sex differences, except for a slightly increased risk for ε3/ε4 female carriers compared to male carriers within the ages of 65 and 75 (Neu et al., 2017). The gene discussed is APOE; the disease is dementia.